Insider · CIK 0001835225

Moran Susan

Reports to the SEC for 4 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001835225

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-02	CBIOCRESCENT BIOPHARMA, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+11.1K sh	—	—	11,050
2026-05-28	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.2K sh	—	—	13,160
2025-06-23	CBIOCRESCENT BIOPHARMA, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+9,023 sh	—	—	9,023
2025-06-18	BCABBioAtla, Inc.A Award	Director	AAward	+23.5K sh	—	—	52,307
2025-05-29	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.2K sh	—	—	22,200
2024-06-13	BCABBioAtla, Inc.A Award	Director	AAward	+16.5K sh	—	—	28,807
2024-05-07	TYRATyra Biosciences, Inc. · Common Stock (Right to Buy)A Award	Director	AAward	+37.2K sh	—	—	37,200
2024-02-26	RayzeBio, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−77.8K sh	—	—	0
2024-02-26	RayzeBio, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−195K sh	—	—	0
2024-02-26	RayzeBio, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−164K sh	—	—	0
2024-02-26	RayzeBio, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−60.8K sh	—	—	0
2024-02-26	RayzeBio, Inc.D Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−323K sh	$62.50	−$20.2M	0
2024-01-22	RayzeBio, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+30.9K sh	$3.24	+$100K	322,647
2024-01-22	RayzeBio, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−30.9K sh	—	—	60,757
2023-11-17	RayzeBio, Inc.Stock Option (right to buy)A Award	CHIEF MEDICAL OFFICER	AAward	+164K sh	—	—	164,000
2023-06-14	BCABBioAtla, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2022-06-16	BCABBioAtla, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-06-15	BCABBioAtla, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.3K sh	—	—	12,307

Recent filings

Accepted (ET)
Jun 34
Moran Susan0001628280-26-040577
SEC(opens sec.gov)
Jun 14
Moran Susan0001193125-26-251538
SEC(opens sec.gov)
Jun 234
Moran Susan0001104659-25-061820
SEC(opens sec.gov)
Jun 184
Moran Susan0000950170-25-088065
SEC(opens sec.gov)
Jun 24
Moran Susan0000950170-25-080228
SEC(opens sec.gov)
Jun 144
Moran Susan0000950170-24-073659
SEC(opens sec.gov)
May 94
Moran Susan0000950170-24-057201
SEC(opens sec.gov)
Feb 274
Moran Susan0001415889-24-005507
SEC(opens sec.gov)
Feb 64
Moran Susan0001415889-24-002852
SEC(opens sec.gov)
Nov 174
Moran Susan0001628280-23-039535
SEC(opens sec.gov)
Jun 154
Moran Susan0001209191-23-037547
SEC(opens sec.gov)
Jun 174
Moran Susan0001209191-22-038170
SEC(opens sec.gov)
Jun 164
Moran Susan0001209191-21-041227
SEC(opens sec.gov)

Companies

Address

C/O/ CRESCENT BIOPHARMA, INC. 300 FIFTH AVENUE

WALTHAM, MA, 02451